Genetically engineered K562 cells augment NK cell cytotoxicity against acute myeloid leukemia and reduce dependency on IL-15.
Saved in:
| Title: | Genetically engineered K562 cells augment NK cell cytotoxicity against acute myeloid leukemia and reduce dependency on IL-15. |
|---|---|
| Authors: | Akhkand SS; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran., Soleimani M; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. soleim_m@modares.ac.ir.; Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. soleim_m@modares.ac.ir., Zomorrod MS; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran., Kiani J; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2025 May 15; Vol. 42 (6), pp. 211. Date of Electronic Publication: 2025 May 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1559-131X |
|---|---|
| DOI: | 10.1007/s12032-025-02769-3 |
